ADVFN Logo ADVFN

Hot Features

Registration Strip Icon for discussion 같은 생각을 가진 투자자들과 토론할 수 있는 활발한 포럼에서 상호 작용하려면 등록하세요.

RLYB Rallybio Holdings LLC

1.49
-0.05 (-3.25%)
26 6월(6) 2024 - 마감
15분 지연
기업명 주식 심볼 시장 주식 타입
Rallybio Holdings LLC RLYB 나스닥 보통주
  가격 변동 가격 변동 % 주식 가격 최근 거래 시간
-0.05 -3.25% 1.49 09:00:00
개장가 저가 고가 종가 전일 종가
1.52 1.42 1.55 1.49 1.54
시세 정보 더보기 »

최근 뉴스

일자 시간 출처 제목
17/06/202421:00BWRallybio Announces Results of Epidemiological Analysis..
22/05/202405:22EDGAR2Form 8-K - Current report
21/05/202413:15EDGAR2Form EFFECT - Notice of Effectiveness
18/05/202406:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
18/05/202406:03EDGAR2Form 4 - Statement of changes in beneficial ownership of..
11/05/202405:02EDGAR2Form S-3 - Registration statement under Securities Act of..
10/05/202405:09EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
09/05/202421:11EDGAR2Form 8-K - Current report
09/05/202421:00BWRallybio Reports First Quarter 2024 Financial Results and..
07/05/202421:00BWRallybio to Present at the 2024 Citizens JMP Life Sciences..
18/04/202405:01BWFNAIT Systematic Literature Review and Meta-Analysis..
11/04/202405:01BWRallybio Announces Collaboration to Advance Therapeutic..
01/04/202423:05BWRallybio Announces FNAIT Systematic Literature Review to be..
12/03/202421:00BWRallybio Reports Fourth Quarter and Full Year 2023 Financial..
26/02/202422:00BWRallybio to Present at the TD Cowen 44th Annual Health Care..
17/02/202408:18EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06/02/202422:15EDGAR2Form 8-K - Current report
06/02/202422:00BWRallybio Announces Portfolio Prioritization and Provides..
04/01/202422:00BWRallybio Highlights Portfolio Advances and Outlines Expected..
20/12/202322:15EDGAR2Form 8-K - Current report
20/12/202322:00BWRallybio Announces Preliminary Phase 1 Multiple Ascending..
10/12/202302:00BWRallybio Presents Natural History Study for Fetal and..
28/11/202321:00BWRallybio Announces Preliminary Multiple Dose Data from the..
10/11/202306:10EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
09/11/202322:10EDGAR2Form 8-K - Current report
09/11/202322:00BWRallybio Reports Third Quarter 2023 Financial Results and..
08/11/202322:00BWRallybio to Present at Upcoming Investor Conferences in..
02/11/202322:15BWRallybio Announces Acceptance of FNAIT Natural History Study..
03/10/202321:00BWRallybio to Present at the JonesTrading 2023 Healthcare..
04/09/202301:00BWRallybio Presents Phase 1 Single Ascending Dose Data for..
31/08/202321:00BWRallybio to Present at Upcoming Investor Conferences in..
09/08/202305:18EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
08/08/202321:16EDGAR2Form 8-K - Current report
08/08/202321:00BWRallybio Reports Second Quarter 2023 Financial Results and..
02/08/202321:00BWRallybio to Present at the 2023 Wedbush PacGrow Healthcare..
11/07/202321:00BWRallybio Announces Acceptance of Abstract for RLYB116 at the..
29/06/202320:30EDGAR2Form 8-K - Current report
29/06/202320:00BWRallybio Announces Succession Plan; Appoints Stephen Uden,..